scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.14.7.1084 |
P698 | PubMed publication ID | 8018664 |
P2093 | author name string | T A Miettinen | |
M J Tikkanen | |||
R S Tilvis | |||
K Kontula | |||
H E Miettinen | |||
J Louhija | |||
P433 | issue | 7 | |
P921 | main subject | genetic variation | Q349856 |
phenotype | Q104053 | ||
P304 | page(s) | 1084-1089 | |
P577 | publication date | 1994-07-01 | |
P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
P1476 | title | Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians | |
P478 | volume | 14 |
Q77894572 | A centenarian-only approach for assessing gene-gene interaction in human longevity |
Q43887708 | A logistic regression model for measuring gene-longevity associations |
Q57629691 | APOE Alleles and Extreme Human Longevity |
Q36998533 | Age, APOE and sex: Triad of risk of Alzheimer's disease |
Q41172424 | Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides |
Q61054673 | Apolipoprotein E alleles in nonagenarian subjects in the Belfast Elderly Longitudinal Free-living Ageing Study (BELFAST) |
Q36532904 | Apolipoprotein E and familial longevity |
Q35538346 | Apolipoprotein E and mortality in African-Americans and Yoruba |
Q36527527 | Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study |
Q52024361 | Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease. |
Q34688023 | Apolipoproteins and aging: emerging mechanisms |
Q37274994 | Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age. |
Q43864519 | Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. |
Q57337171 | Association of apolipoprotein (Apo)E genotype with plasma apo E levels |
Q24796377 | Association of apolipoprotein E genotypes, blood pressure, blood lipids and ECG abnormalities in a general population aged 85+ |
Q43906238 | Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes |
Q37414468 | Centenarians--a useful model for healthy aging? A 29-year follow-up of hospitalizations among 40,000 Danes born in 1905 |
Q34071528 | Common gene variants, mortality and extreme longevity in humans. |
Q52029704 | Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. |
Q44325087 | Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity |
Q73194210 | Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients |
Q74308758 | Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes |
Q34280870 | Exact sample size needed to detect dependence in 2 x 2 x 2 tables. |
Q74190817 | Exercise-induced silent myocardial ischemia in master athletes |
Q73574820 | Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis |
Q40940199 | Genetic and aging epidemiology. The merging of two disciplines |
Q37214302 | Genetic epidemiology in aging research |
Q21143740 | Genetic variation in healthy oldest-old |
Q54105736 | Genetics of longevity. |
Q47987141 | In search of a biological pattern for human longevity: impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians |
Q81695724 | Laboratory parameters of Italian centenarians |
Q38988292 | Limitations and risks of meta-analyses of longevity studies |
Q35166293 | Methodological Considerations in Studying Centenarians: Lessons Learned From the Georgia Centenarian Studies. |
Q52034585 | Modeling the effects of genetic factors on late-onset diseases in cohort studies. |
Q36192488 | Molecular determinants of human longevity |
Q44564480 | Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis |
Q39654157 | Ninety-seven-year-old people: general presentation, and some general and medical characteristics from a Swedish population study |
Q60049384 | Positive association of familial longevity with the moderate-high HDL-C concentration in Bama Aging Study |
Q35881544 | Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. |
Q64087216 | The Genetic Variability of in Different Human Populations and Its Implications for Longevity |
Q30248596 | The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts |
Q38463404 | The association of apolipoprotein E polymorphism with memory: a population based study |
Q92252120 | The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE) |
Q44654924 | The normal population distribution of PRNP codon 129 polymorphism |
Q37779889 | The role of genetic variants in human longevity |
Q37413113 | Total and cause-specific mortality in the cardiovascular health study |
Q37072970 | Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population |
Q74622617 | Variations of cardiovascular disease associated genes exhibit sex-dependent influence on human longevity |
Q73821380 | You may live to the age of more than 100 years even if you are homozygous for a haemochromatosis gene mutation |
Search more.